Company intelligence

Jaguar Health

BiotechSan Francisco, California, USA

Recent changes

  1. Jul 15, 2026Jaguar Health, Vogenx Join a Growing Biotech S-1 Queue Pulse story
  2. Jun 9, 2026Raised $2M SEC EDGAR Form D

Funding History

1 event ยท sources dated per row
DateEventAmountValuationInvestorsSource
Jun 9, 2026funding round$2Mโ€”
SEC EDGAR Form D

Latest Pulse

  1. Seven Companies File S-1s in a Single WeekSeven companies spanning biotech, fintech, AI and battery materials filed IPO registration paperwork with the SEC within days of each other, a broad-based cluster that extends the sustained widening of 2026's listing pipeline.โ†’
  2. The IPO Pipeline Is Quietly Getting LongerValue Add Pulse analysis: the mix of filings landing in mid-July 2026 -- SPAC revival, sustained biotech S-1s, mega-cap AI IPO prep and a wobbling SpaceX debut -- shows a pipeline broadening in kind, not just size.โ†’
  3. Jaguar Health, Vogenx Join a Growing Biotech S-1 QueueJaguar Health and Vogenx both filed S-1 paperwork with the SEC, adding to a biotech IPO queue that's grown steadily through 2026 as public-market appetite for clinical-stage listings recovers.โ†’

Coverage Timeline

newest first
  1. Jul 15, 2026IPOJaguar Health, Vogenx Join a Growing Biotech S-1 Queueโ†’

All Coverage

Related Companies

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data ยท Suggest a correction